2025 Event Programme
Programme is subject to change
Registration and Coffee
Welcome
Professors Richard Kitney and Paul Freemont, Co-Directors, SynbiCITE
Keynote: Synbio’s Role in the Race to Net Zero
Speaker TBA
Panel Introduction
Lord David Willetts, Chair of the Regulatory Innovation Office
Panel Discussion: Regulation
Lord David Willetts, Chair of the Regulatory Innovation Office
Olon Biotech
Coffee Break
Company Presentations: Scaling Success
- Nigel Scrutton, Co-Founder and CSO, C3Biotechnologies
- Gustaf Hemberg, CEO and Co-Founder, Scindo
Plenary Session
Lunch
Five Key (non technical) Developments in Synthetic Biology: an American Perspective
Rick Johnson, Director of BioMade, Distinguished Visiting Fellow at the Hoover Institution and Stanford
Panel Discussion: Policy
Patrick Rose, Innovation Manager, SPRIND
Plenary Session: IP Law
Sara Holland, Partner and Patent Attorney, Potter Clarkson
Company Presentations
- Alicia Showering, CEO and Co-Founder, Bugbiome
- Joe Price, Founder, Evolutor
- Harsh Amin, CEO and Chief Scientific Officer, Ivy Farm Technologies
- Meir Wachs, CEO, Kyomei
- David Venables, CEO, Laverock Therapeutics
- Pedro Correa de Sampaio, CEO and Co-Founder, Neobe Therapeutics
- Prantar Tamuli, Founder, Tattva
- Ben Wilding, CEO, Sun Bear Biofuture
Tea Break
Plenary Session
NPL
Plenary Session: Infrastructure and Scale-Up
Synbio Unplugged
Champagne Reception
Arrival and Coffee
Keynote
Chris Voigt, Daniel I.C. Wang Professor and Head of Department of Biological Engineering, MIT
Plenary Session
Mary Maxon, Executive Vice President, Carnegie Sciences
Panel Discussion: International Policy
Coffee Break
Plenary
Panel Discussion
Plenary Session
Makiko Matsuo, Project Associate Professor at the Graduate School of Public Policy, The University of Tokyo
Company Reviews
- Daniel Hansen, CEO and Co-Founder, Bactobio
- Jevan Nagarajah, Better Dairy
Plenary Session
Keltie
Devanand Crease, Partner and Chartered Patent Attorney, Keltie
Plenary Session
Lunch
Plenary Session: Investment Banking for Synthetic Biology
Panel Discussion: Finance and Investment
Joško Bobanović, Partner, Sofinnova Partners